Showing results (331-340 of 365) with videos related to

Sort By:
Pageof 37
Immunotargets and Therapy|February 8, 2024
Identification of CXC Chemokine Receptor 2 (CXCR2) as a Novel Eosinophils-Independent Diagnostic Biomarker of Pediatric Eosinophilic Esophagitis by Integrated Bioinformatic and Machine-Learning AnalysisJunhao Wu, Caihan Duan, Chaoqun Han, et al.
Immunotargets and Therapy|January 30, 2024
In-vivo Immunomodulatory Activities of Essential Oils of Artemisia abyssinica and Lepidium sativum in MiceKassahun Dires Ayenew, Amare Ayalew, Yehualashet Teshome Wondmkun, et al.
Immunotargets and Therapy|January 15, 2024
CD69 is a Promising Immunotherapy and Prognosis Prediction Target in CancerYuchen Li, Yinfeng Gu, Pengyue Yang, et al.
Immunotargets and Therapy|September 16, 2024
Survival Benefit of Lenvatinib Plus PD-1 Inhibitor with or Without HAIC in Advanced Hepatocellular Carcinoma Beyond Oligometastasis: a Multicenter Cohort StudyMurong Wang, Qunfang Zhou, Hui Li, et al.
Immunotargets and Therapy|September 18, 2024
Thrombopoietin Receptor Agonists in Post-Hematopoietic Cell Transplantation Complicated by Prolonged Thrombocytopenia: A Comprehensive ReviewAbdelrahman Elsayed, Basant Elsayed, Mohamed Elmarasi, et al.
Immunotargets and Therapy|March 4, 2024
Characterizing CD8+ TEMRA Cells in CP/CPPS Patients: Insights from Targeted Single-Cell Transcriptomic and Functional InvestigationsFei Zhang, Qintao Ge, Jialin Meng, et al.
Immunotargets and Therapy|February 23, 2024
Males' Access to Human Papillomavirus Vaccination in Resource-Limited SettingsWubishet Gezimu, Firomsa Bekele, Teshome Bekana, et al.
Immunotargets and Therapy|February 14, 2024
The Age-Male-Albumin-Bilirubin-Platelets (aMAP) Risk Score Predicts Liver Metastasis Following Surgery for Breast Cancer in Chinese Population: A Retrospective StudyLi Chen, Qiang Liu, Chunlei Tan, et al.
Immunotargets and Therapy|November 6, 2023
Globoid Cell Leukodystrophy (Krabbe Disease): An UpdateAzzam A Maghazachi
Immunotargets and Therapy|February 19, 2026
Enhancing NK Cell Activity in Colorectal Cancer with an Fc-Optimized Antibody Targeting CD276 (B7-H3)Sylwia A Stefańczyk, Xenija Kaiser, Ilona Hagelstein, et al.
Pageof 37